# Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI

> **NCT04550377** · PHASE2 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 120 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder
- Traumatic Brain Injury

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04550377
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-26
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04550377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04550377, "Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04550377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*